Dr. Benjamin R. Griffin, MD

Dr. Griffin practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Griffin's NPI, 1568726529, was assigned on June 25, 2012. Dr. Griffin graduated from University of Miami, Lm Miller School of Medicine in 2012. Dr. Griffin holds Iowa license MD-46392.

Dr. Griffin's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Griffin's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Griffin is also affiliated with University of Iowa Health Care Medical Center Downtown. The medical group on file is Scanlan Center for School Mental Health Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Griffin practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Griffin's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Griffin's licenses on file in 3 states: Iowa, Colorado and Minnesota.

CMS data shows 506 Medicare services from Dr. Griffin across 7 procedure codes in 2024, for 198 Medicare patients. Medicare paid $38,494 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 198 Medicare patients who saw Dr. Griffin in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 4.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Griffin's median patient age at 69, with 43% women.

In 2024, Dr. Griffin wrote 374 Medicare Part D claims for 73 patients. 85% of them were for generic drugs. CMS names the drug for 247 of them, across 10 drugs with 11 or more claims each, at $33,447 in total drug cost. In 2023, CMS named 191 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Griffin for performance year 2024, reported as part of a group. Dr. Griffin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Griffin. Dr. Griffin has published most often in Mayo Clin Proc. Dr. Griffin's most frequent co-authors are Carrie A. Schinstock, MD, Christopher R. Stephenson, MD and Mark E. Wylam, MD.

CMS Open Payments shows 1 general payment to Dr. Griffin from 1 drug or device company in 2025. Consulting fees make up the largest share, 100% of the total. Daxor Corporation paid the most, $6,050.

Dr. Griffin graduated from University of Miami, Lm Miller School of Medicine in 2012.